Abstract
Session presented on: Tuesday, July 23, 2013:
Purpose: The Sepsis Resuscitation Bundle (SRB) should be implemented for the management of severe sepsis, septic shock, or lactic acid > 4 mmol/l with confirmed or suspected infection according to the evaluation of available evidence. The clinical question looked to answer whether only partial early goal-directed therapy (EGDT), the SRB, could be used and still demonstrate a positive impact on mortality.
Methods: Systematic review of eight articles and the practice guideline were analyzed for applicability, strength of the evidence, validity of the results, and gaps in the studies' findings. The articles revealed evidence that using SRB reduced mortality. Rivers et al. 1 conducted research without gaps in their study and the clinical question asked. This correlation was strengthened by the study design's meta-analysis of over 50 publications and large sample size of over 18,000 adults. Although the studies included in the meta-analysis were not randomized controlled trials, clinical criteria were met making it the most influential findings for application to practice.
Results: There was variability in the interventions applied in the reviewed studies. Five of the studies and practice guideline used EGDT as the intervention. The two out of the eleven studies that researched the unmodified SRB, both meta-analyses representing levels of evidence III and IV, demonstrated a clinically significant reduction in mortality. Rivers et al. 1 meta-analysis of cohort studies provided the strongest evidence to support use of the SRB by demonstrating a RRR of 0.37, ARR of 18.3%, NNT of 5.45, and a crude mortality reduction of 17.7%.
Conclusion: Evidence identified through a systematic review of current research supported the use of the SRB independently to reduce mortality in adult patients with severe sepsis, septic shock, or lactic acid > 4 mmol/l with confirmed or suspected infection admitted to acute care facilities.
Sigma Membership
Non-member
Type
Presentation
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Septic Shock, Sepsis Resuscitation Bundle, Sepsis
Recommended Citation
Roney, Jamie K. and Pinelle, Michelle A., "Answering the clinical question of mortality benefit from using the sepsis resuscitation bundle alone" (2013). INRC (Congress). 76.
https://www.sigmarepository.org/inrc/2013/presentations_2013/76
Conference Name
24th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Prague, Czech Republic
Conference Year
2013
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Review Type
Abstract Review Only: Reviewed by Event Host
Acquisition
Proxy-submission
Answering the clinical question of mortality benefit from using the sepsis resuscitation bundle alone
Prague, Czech Republic
Session presented on: Tuesday, July 23, 2013:
Purpose: The Sepsis Resuscitation Bundle (SRB) should be implemented for the management of severe sepsis, septic shock, or lactic acid > 4 mmol/l with confirmed or suspected infection according to the evaluation of available evidence. The clinical question looked to answer whether only partial early goal-directed therapy (EGDT), the SRB, could be used and still demonstrate a positive impact on mortality.
Methods: Systematic review of eight articles and the practice guideline were analyzed for applicability, strength of the evidence, validity of the results, and gaps in the studies' findings. The articles revealed evidence that using SRB reduced mortality. Rivers et al. 1 conducted research without gaps in their study and the clinical question asked. This correlation was strengthened by the study design's meta-analysis of over 50 publications and large sample size of over 18,000 adults. Although the studies included in the meta-analysis were not randomized controlled trials, clinical criteria were met making it the most influential findings for application to practice.
Results: There was variability in the interventions applied in the reviewed studies. Five of the studies and practice guideline used EGDT as the intervention. The two out of the eleven studies that researched the unmodified SRB, both meta-analyses representing levels of evidence III and IV, demonstrated a clinically significant reduction in mortality. Rivers et al. 1 meta-analysis of cohort studies provided the strongest evidence to support use of the SRB by demonstrating a RRR of 0.37, ARR of 18.3%, NNT of 5.45, and a crude mortality reduction of 17.7%.
Conclusion: Evidence identified through a systematic review of current research supported the use of the SRB independently to reduce mortality in adult patients with severe sepsis, septic shock, or lactic acid > 4 mmol/l with confirmed or suspected infection admitted to acute care facilities.